UK approves Pfizer-BioNTech COVID-19 vaccine,First COVID-19 vaccine in the world
Published On: Wednesday, December 2, 2020 | By: Team KnowMyStock
Shares of Pfizer gained 5 per cent to Rs 5384.95 after the U.K.country approved a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE’s shot ahead of decisions in the U.S. and European Union. The UK became the first country to approve Covid-19 Vaccine and will be available in Britain from next week, according to a government statement. The British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe for rollout. The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year. The vaccine will be manufactured in BioNTech’s German sites, as well as Pfizer’s manufacturing site in Belgium.
The UK government said the vaccine needs to be stored in a fridge and has an effective life of up to five days at temperatures of 2 to 8 degrees.
Pfizer said Britain’s emergency use authorization marks a historic moment in the fight against COVID-19. "This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the UK,” said Pfizer CEO Albert Bourla.
We are on Telegram!
JOIN our telegram channel to receive updates on Financial News and Stock and FNO Tips.
Click Here!
Follow Us On:
